LIQUIDIA CORPORATION (LQDA) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
41/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 8 wins, 4 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinLQDA / S&P 111.26% / 15.20% |
WinLQDA / S&P 2233.65% / 15.00% |
LoseLQDA / S&P -177.22% / 50.40% |
| 2026-Q12/3 |
WinLQDA / S&P 9.42% / -4.33% |
WinLQDA / S&P 1936.66% / 11.30% |
LoseLQDA / S&P -109.47% / 27.70% |
| 2025-Q42/3 |
WinLQDA / S&P 51.67% / 2.65% |
WinLQDA / S&P 1031.18% / 9.00% |
LoseLQDA / S&P -50.61% / 13.40% |
| 2025-Q32/3 |
WinLQDA / S&P 82.50% / 8.12% |
WinLQDA / S&P 343.41% / 4.61% |
LoseLQDA / S&P -10.00% / 13.45% |
| 2025-Q22/3 |
LoseLQDA / S&P -15.53% / 10.94% |
WinLQDA / S&P 30.20% / 4.83% |
WinLQDA / S&P 25.00% / 10.63% |
| 2025-Q12/3 |
WinLQDA / S&P 25.43% / -4.27% |
LoseLQDA / S&P -11.42% / 4.98% |
WinLQDA / S&P 19.01% / 10.57% |
| 2024-Q42/3 |
WinLQDA / S&P 17.60% / 2.41% |
LoseLQDA / S&P -19.97% / 5.25% |
WinLQDA / S&P 36.67% / 6.15% |
| 2024-Q31/3 |
LoseLQDA / S&P -16.67% / 5.89% |
LoseLQDA / S&P -14.78% / 5.89% |
WinLQDA / S&P 83.91% / 6.11% |
| 2024-Q21/3 |
LoseLQDA / S&P -18.64% / 4.28% |
LoseLQDA / S&P -16.65% / 5.38% |
WinLQDA / S&P 87.01% / 5.12% |
| 2024-Q12/3 |
WinLQDA / S&P 22.61% / 10.56% |
LoseLQDA / S&P -5.72% / 5.71% |
WinLQDA / S&P 153.57% / 5.59% |
| 2023-Q43/3 |
WinLQDA / S&P 89.75% / 11.69% |
WinLQDA / S&P 9.75% / 6.81% |
WinLQDA / S&P 76.47% / 7.78% |
| 2023-Q32/3 |
LoseLQDA / S&P -19.24% / -3.27% |
WinLQDA / S&P 32.83% / 7.52% |
WinLQDA / S&P 6.10% / -5.03% |
| 2023-Q23/3 |
WinLQDA / S&P 13.60% / 8.74% |
WinLQDA / S&P 28.98% / 9.50% |
WinLQDA / S&P -6.10% / -8.57% |
| 2023-Q12/3 |
WinLQDA / S&P 8.48% / 7.50% |
WinLQDA / S&P 27.70% / 10.77% |
LoseLQDA / S&P -30.00% / -15.69% |
| 2022-Q43/3 |
WinLQDA / S&P 17.10% / 7.56% |
WinLQDA / S&P 23.97% / 11.88% |
WinLQDA / S&P -4.23% / -17.99% |
| 2022-Q32/3 |
WinLQDA / S&P 24.77% / -4.88% |
WinLQDA / S&P 32.87% / 13.47% |
LoseLQDA / S&P LQDA unavailable / -1.41% |
| 2022-Q21/3 |
LoseLQDA / S&P -39.28% / -16.10% |
WinLQDA / S&P 91.73% / 13.71% |
LoseLQDA / S&P LQDA unavailable / 11.04% |
| 2022-Q12/3 |
WinLQDA / S&P 47.43% / -4.60% |
WinLQDA / S&P 246.84% / 15.97% |
LoseLQDA / S&P LQDA unavailable / 42.23% |
| 2021-Q42/3 |
WinLQDA / S&P 76.45% / 11.03% |
WinLQDA / S&P 1637.90% / 15.00% |
LoseLQDA / S&P LQDA unavailable / 96.40% |
| 2021-Q30/3 |
LoseLQDA / S&P -3.50% / 0.58% |
LoseLQDA / S&P LQDA unavailable / 10.77% |
LoseLQDA / S&P LQDA unavailable / 69.42% |
| 2021-Q20/3 |
LoseLQDA / S&P 6.32% / 8.55% |
LoseLQDA / S&P LQDA unavailable / 6.58% |
LoseLQDA / S&P LQDA unavailable / 51.81% |
| 2021-Q10/3 |
LoseLQDA / S&P -8.81% / 6.17% |
LoseLQDA / S&P LQDA unavailable / -1.06% |
LoseLQDA / S&P LQDA unavailable / 7.39% |
| 2020-Q40/3 |
LoseLQDA / S&P -40.04% / 12.15% |
LoseLQDA / S&P LQDA unavailable / -3.72% |
LoseLQDA / S&P LQDA unavailable / -33.42% |
| 2020-Q30/3 |
LoseLQDA / S&P -41.57% / 8.93% |
LoseLQDA / S&P LQDA unavailable / -2.04% |
LoseLQDA / S&P LQDA unavailable / -27.10% |
| 2020-Q21/3 |
WinLQDA / S&P 78.77% / 20.54% |
LoseLQDA / S&P LQDA unavailable / -0.46% |
LoseLQDA / S&P LQDA unavailable / -27.11% |
| 2020-Q11/3 |
WinLQDA / S&P 10.05% / -19.60% |
LoseLQDA / S&P LQDA unavailable / 3.47% |
LoseLQDA / S&P LQDA unavailable / -14.75% |
| 2019-Q41/3 |
WinLQDA / S&P 20.22% / 9.07% |
LoseLQDA / S&P LQDA unavailable / 5.36% |
LoseLQDA / S&P LQDA unavailable / 2.99% |
| 2019-Q30/3 |
LoseLQDA / S&P -55.50% / 1.70% |
LoseLQDA / S&P LQDA unavailable / 5.02% |
LoseLQDA / S&P LQDA unavailable / 0.21% |
| 2019-Q20/3 |
LoseLQDA / S&P -29.70% / 4.30% |
LoseLQDA / S&P LQDA unavailable / 6.64% |
LoseLQDA / S&P LQDA unavailable / 8.65% |
| 2019-Q10/3 |
LoseLQDA / S&P -47.46% / 13.65% |
LoseLQDA / S&P LQDA unavailable / 8.12% |
LoseLQDA / S&P LQDA unavailable / 14.29% |
| 2018-Q40/3 |
LoseLQDA / S&P -21.04% / -13.52% |
LoseLQDA / S&P LQDA unavailable / 9.05% |
LoseLQDA / S&P LQDA unavailable / 18.23% |
| 2018-Q30/3 |
LoseLQDA / S&P LQDA unavailable / 7.71% |
LoseLQDA / S&P LQDA unavailable / 10.21% |
LoseLQDA / S&P LQDA unavailable / 19.06% |
| 2018-Q20/3 |
LoseLQDA / S&P LQDA unavailable / 3.43% |
LoseLQDA / S&P LQDA unavailable / 9.03% |
LoseLQDA / S&P LQDA unavailable / 14.46% |
| 2018-Q10/3 |
LoseLQDA / S&P LQDA unavailable / -0.76% |
LoseLQDA / S&P LQDA unavailable / 7.68% |
LoseLQDA / S&P LQDA unavailable / 12.46% |
| 2017-Q40/3 |
LoseLQDA / S&P LQDA unavailable / 6.64% |
LoseLQDA / S&P LQDA unavailable / 7.03% |
LoseLQDA / S&P LQDA unavailable / 13.82% |
| 2017-Q30/3 |
LoseLQDA / S&P LQDA unavailable / 4.48% |
LoseLQDA / S&P LQDA unavailable / 5.68% |
LoseLQDA / S&P LQDA unavailable / 17.57% |
| 2017-Q20/3 |
LoseLQDA / S&P LQDA unavailable / 3.09% |
LoseLQDA / S&P LQDA unavailable / 4.83% |
LoseLQDA / S&P LQDA unavailable / 17.74% |
| 2017-Q10/3 |
LoseLQDA / S&P LQDA unavailable / 6.07% |
LoseLQDA / S&P LQDA unavailable / 3.67% |
LoseLQDA / S&P LQDA unavailable / 13.32% |
| 2016-Q40/3 |
LoseLQDA / S&P LQDA unavailable / 3.82% |
LoseLQDA / S&P LQDA unavailable / 2.09% |
LoseLQDA / S&P LQDA unavailable / 7.05% |
| 2016-Q30/3 |
LoseLQDA / S&P LQDA unavailable / 3.85% |
LoseLQDA / S&P LQDA unavailable / 0.20% |
LoseLQDA / S&P LQDA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LQDA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 152.67% | 20.78% |
| Annualized return | 152.67% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LQDA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 2397.86% | 83.14% |
| Annualized return | 90.33% | 12.86% |
10Y · 2018-07-26 to 2026-08-27
| Metric | LQDA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 530.09% | 319.30% |
| Annualized return | 20.21% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |